clinical trial · NCT06866613
Phase III Trial to Evaluate the Efficacy and Safety in Patients With Ankle Sprains.
Teikoku Seiyaku Co., Ltd.·phase3·completed·n = 69
Ankle SprainsEsflurbiprofen Topical System (EFTS)Placebo Patch
brief summary
This study is a multi-center, double-blind, randomized controlled trial to evaluate the efficacy and safety of EFTS vs. placebo in patients with ankle sprains. The primary objective of this study is to demonstrate that the EFTS is superior in pain reduction compared to a matching placebo in patients with ankle sprains. The secondary objective is to evaluate tolerability, local tolerability, and adhesion of EFTS vs. placebo.
started
Mar 31, 2025
primary completion
Oct 18, 2025
completion
Oct 30, 2025
last updated
Nov 26, 2025
official title
Randomized, Controlled, Double-blind, Multi-center Trial to Evaluate the Efficacy and Safety of an Esflurbiprofen Topical System (EFTS) vs. Placebo in the Local Symptomatic and Short-term Treatment of Pain in Ankle Sprains.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol